What is HUMATE-P
HUMATE-P is a VWF/FVIII replacement therapy that delivers results, patient after patient, treatment after treatment, decade after decade, as proven by a US study of the hemostatic efficacy of HUMATE-P. Based on this study, an independent Data Safety Monitoring Board judged hemostatic efficacy as "effective in 94.3% of the perioperative study subjects."
HUMATE-P is a human plasma-derived von Willebrand factor (HP-VWF/FVIII) concentrate that:
- Is approved for the treatment of VWD and for the prevention of excessive bleeding during and after surgery
- Can be used for prevention of bleeding during and after surgery in all VWD types and for all procedures
HUMATE-P works by replacing the VWF/FVIII complex that is deficient or abnormal in patients with von Willebrand disease. The HP-VWF/FVIII concentrate is purified from pooled human plasma from many carefully screened plasma donors and contains the clotting proteins VWF and FVIII